Ballicules.com

Trientine

SYPRINE

Pronunciation: TRYE-en-teen

Trientine ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Trientine ballicule

What it isCopper chelator; Wilson disease in patients intolerant of penicillamine.

Why this oneBetter tolerated than penicillamine with far less autoimmune and marrow toxicity.

What limits itIron deficiency from chelation, and it must be taken on an empty stomach away from iron. Less potent than penicillamine.

Trientine molecular structure (skeletal formula)
Molecular structure: Trientine

FDA label

FDA dosingPopulationStartTargetMax
Wilson's disease (penicillamine-intolerant)Adults750–1250 mg/day divided BID–QID—2000 mg/day
Wilson's diseasePediatric (age ≤12)500–750 mg/day divided BID–QID—1500 mg/day

Titration Increase only when clinical response is inadequate or free serum copper is persistently above 20 mcg/dL

Renal Undefined

Hepatic Undefined

Reassess optimal long-term maintenance dosage every 6 to 12 months

Instructions

Available strengths

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

Cost

Trientine (SYPRINE)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/moCostPlus
250 mgcap60 BID$138.15offered
500 mgcap60 BIDnot offered

Generic entry2039 est.

NO BOXED WARNINGS

Principal riskIron deficiency; take on an empty stomach

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryNot assigned — PLLR-era drug

Defining liabilityAgent-specific cardiovascular, neurologic or metabolic toxicity requires monitored use in poisoning or overload.

Open Trientine in the interactive console ↗